Information about Cmax Biotech Consulting
My details
*
*
*

Cmax Biotech Consulting (SRL)

Company information

Status
Active

Enterprise number

BE0784.922.317

VAT liability
Yes
Established
19-04-2022
Last balance sheet year
2024
Company size
Micro 0 FTE
Principal activity
Research and development in other physical and natural sciences
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Cmax Biotech Consulting

2024 2023 2022
Profit/Loss 74,864 15 % 65,349 97 % 33,212
Equity 77,424 -25 % 102,560 176 % 37,212
Gross margin 98,079 14 % 85,823 91 % 44,849

Publications from Cmax Biotech Consulting

Date Publication
21-04-2022 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Cmax Biotech Consulting?
The VAT number of Cmax Biotech Consulting is BE 0784.922.317.
Wat is the PEPPOL ID of Cmax Biotech Consulting?
There is no information available about the PEPPOL ID of Cmax Biotech Consulting or the company is not yet registered on the PEPPOL network.
When was Cmax Biotech Consulting founded?
Cmax Biotech Consulting was founded on 19-04-2022.
What is the address of Cmax Biotech Consulting?
The current registered office of Cmax Biotech Consulting is located at Bremstraat 24, 3511 Hasselt.
When was the last time Cmax Biotech Consulting filed their annual financial statements?
The most recent financial statements of Cmax Biotech Consulting were filed on 21-03-2025.
How many employees does Cmax Biotech Consulting have?
There are currently no employees working at Cmax Biotech Consulting or no workforce information is available.
What is the annual turnover of Cmax Biotech Consulting?
At the time of its most recent financial statements, Cmax Biotech Consulting did not publish any turnover figures. Cmax Biotech Consulting reported a gross margin of €98,079.47.